文献速递认知障碍与痴呆

淀粉样蛋白与tau蛋白对老年人前瞻性认知下降的影响

The impact of amyloid-beta and tau on prospective cognitive decline in older individuals.
PubMed 文献 · Ann Neurol · 2019-01-21

OBJECTIVES: Amyloid-beta (Aβ) and tau pathologies are commonly observed among clinically normal older individuals at postmortem and can now be detected with in vivo neuroimaging.…

要点

  • Aβ和tau水平升高均与记忆下降相关,但与执行功能变化无关。
  • 皮层Aβ越高,各感兴趣区tau水平越高,独立于年龄。
  • Aβ和tau双高者前瞻性记忆下降更快,存在显著交互作用。

核心结论

  • Aβ和tau共同参与临床前阿尔茨海默病的记忆下降,二者均必要。

主要发现

  • 较高的Aβ和tau水平均与更大的记忆下降相关,但与执行功能变化无关。
  • 较高的皮层Aβ与所有感兴趣区更高的tau水平相关,独立于年龄。
  • tau和Aβ在感兴趣区和顶点分析中均存在显著交互作用,双高者记忆下降更快。

临床怎么用

  • 在临床前AD阶段,联合评估Aβ和tau PET有助于识别记忆下降风险高的个体。
  • 该发现可为临床前AD的二级预防试验提供参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Amyloid-beta (Aβ) and tau pathologies are commonly observed among clinically normal older individuals at postmortem and can now be detected with in vivo neuroimaging. The association and interaction of these proteinopathies with prospective cognitive decline in normal aging and preclinical Alzheimer's disease (AD) remains to be fully elucidated. METHODS: One hundred thirty-seven older individuals (age = 76.3 ± 6.22 years) participating in the Harvard Aging Brain Study underwent Aβ (11 C-Pittsburgh compound B) and tau (18 F-flortaucipir) positron emission tomography (PET) with prospective neuropsychological assessments following PET imaging (mean number of cognitive visits = 2.8 ± 1.1). Tau and Aβ PET measures were assessed in regions of interest (ROIs) as well as vertex-wise map analyses. Cognitive change was evaluated with Memory and Executive Function composites. RESULTS: Higher levels of Aβ and tau were both associated with greater memory decline, but not with change in executive function. Higher cortical Aβ was associated with higher tau levels in all ROIs, independent of age, and very elevated levels of tau were observed primarily in clinically normal with elevated Aβ. A significant interaction between tau and Aβ was observed in both ROI and map-level analyses, such that rapid prospective memory decline was observed in participants who had high levels of both pathologies. INTERPRETATION: Our results are consistent with the supposition that both Aβ and tau are necessary for memory decline in the preclinical stages of AD. These findings may be relevant for disambiguating aging and early cognitive manifestations of AD, and to inform secondary prevention trials in preclinical AD. Ann Neurol 2019;00:1-3 ANN NEUROL 2019;85:181-193.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Sperling RA, Mormino EC, Schultz AP, et al. The impact of amyloid-beta and tau on prospective cognitive decline in older individuals. Ann Neurol. 2019. PMID: 30549303. doi:10.1002/ana.25395

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。